DendroPharm GmbH

Key figures / Profile

• Develop nano carriers to improve drug penetration into skin, tumors and inflamed tissue
• established a validated route of nanocarrier synthesis
• used nanocarriers as excipient for a veterinary dermal formulation
• ISO 9001 certified since 2015

We offer

• Drug formulation especially using our proprietary nano-carrier platform technology
• In-vitro transdermal studies for drug formulation development
• Toxicology rat dermal absorption and metabolism studies
• Clinical trial samples production (from 2019 onwards)
• Regulatory Affairs management, veterinary medicine dossier writing, exchange with authorities, veterinary clinical study planning & management,
• Nanocarrier and other organic chemistry synthesis and nanomaterial & protein purification using diafiltration